Search and apply for every grant in existence.

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Transformative Breast Cancer Consortium Development Award provides successful applicants the time and resources needed to bring investigators and breast cancer consumer advocates together to establish a consortium framework and conduct preliminary research in support of an application to a future, full BCRP Transformative Breast Cancer Consortium Award (pending availability of funds). All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception.Distinctive Features:· This is a development award and is a separate award mechanism from the full FY26 BCRP Transformative Breast Cancer Consortium Award (HT942526BCRPTBCCA). For FY26, investigators may be named as Consortium Director on an application submitted to either (but not both) of these award mechanisms.· Breast cancer consumer advocates must be active participants in the development and execution of the FY26 BCRP TBCCDA. Funding Opportunity Number: HT942526BCRPTBCCDA. Assistance Listing: 12.420. Funding Instrument: CA. Category: ST. Award Amount: $140K total program funding.

This is a notice of funding opportunity (NOFO) for the OVC FY 2026 Victims of Crime Act (VOCA) Victim Assistance Formula Grant. This opportunity provides an annual VOCA victim assistance grant to all states and most territories to provide subgrants to local organizations and public agencies that provide services directly to crime victims. Examples of services provided include crisis counseling, telephone and onsite information and referrals, criminal justice support and advocacy, shelter, therapy, and additional assistance. Funding Opportunity Number: O-OVC-2026-172627. Assistance Listing: 16.575. Funding Instrument: G. Category: ISS.

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Era of Hope Scholar Award supports individuals who are early in their careers with significant potential to effect meaningful change in breast cancer. As the Intent of the FY26 BCRP Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the award’s central features include the Principal Investigator’s (PI’s) demonstrated ability to go beyond conventional thinking in their field and the innovative and meaningful contributions that they can make toward ending breast cancer. The Era of Hope Scholar Award requires exceptionally talented scientists that are among “the best and the brightest” in their field(s), with demonstrated experience forming effective partnerships and collaborations and strong potential for future leadership in breast cancer research. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception.Distinctive Features:· The PI must commit a minimum of 25% level of time and effort during the period of performance to conduct breast cancer research under this award.· The research team must include two or more breast cancer consumer advocates. Funding Opportunity Number: HT942526BCRPEOHS. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $4.9M total program funding.